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Periodontal disease is a collective term of inflammatory conditions of the 
periodontium and chronic periodontitis is considered as most common form.  Chronic 
periodontitis is an infectious disease resulting in inflammation within the supporting 
tissues of the teeth, progressive attachment loss, and bone loss and is characterized by 
periodontal pocket formation and/or recession of the gingiva.1 
 Chronic periodontitis is a polymicrobial and multifactorial, inflammatory 
disease of the investigating tissues of the periodontium which is often instigated by 
the plaque biofilm containing putative periodontal pathogens like Porphyromonas 
gingivalis, Aggregatibacter actinomycetemcomitans resulting in destruction of tooth 
supporting structures. 
Porphyromonas gingivalis is a non – motile, gram negative, anaerobic, non-
fermentative, pigmented, non-sporing bacillus. It is formerly called as Bacteroides 
gingivalis. It is often involved in causing chronic periodontitis 1 
The therapeutic management of chronic periodontitis mainly focusses on 
reducing the microbial load, restoring the normal flora of periodontal pocket and also 
changing its environment to prevent its further progression. 
The conventional periodontal treatment encompasses of mechanical 
debridement (scaling and root planing) which reduces the microbial load along with 
the plaque and calculus, however it does not eradicate all the pathogens from the 
subgingival environment which are residing deep in to the connective tissues to 
recolonize later. 
 To overcome the limitations of this conventional treatment, chemical agents 
as antibiotics and antiseptics have been used successfully to treat moderate to severe 
periodontal disease by systemic administration2.On the long run systemic antibiotics 
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produced bacterial resistance and untoward side effects due to its administration in 
larger doses for longer time to obtain therapeutic concentrations at the site of 
infection. 
In order to resolve the disadvantages of systemic administration, local drug 
delivery systems have been introduced which delivers the desired drug to the target 
site. Various locally delivered agents that are successfully used include tetracycline 
fibres3, 10% doxycycline4, 2% minocycline5, metronidazole6 and chlorhexidine 
gluconate7, but none are without side effects. 
Recent research is being focused on the herbal products instead of artificial 
chemicals. Plethora of studies have been done and documented about the medicinal 
values of herbal products, and its formulations are made available commercially. One 
such herbal plant of interest is Tulsi (ocimum sanctum) which are portrayed as “queen 
of herbs” in the ancient literature of medicine7. 
In ancient literature, ocimum sanctum is considered as a sacred medicinal 
plant and is frequently mentioned as one of the main pillars of herbal medicine. Tulsi 
has been renowned as a general tonic and vitalizer, “The Elixir of Life.” 8  
Oil of O. sanctum contains five fatty acids (stearic, palmitic, linoleic, oleic and 
linolenic acids) which is considered to be a good source of beta carotene, calcium, 
vitamin C. Also, it contains various volatile substances (including estragol, eugenol, 
linalool, methyl chavicol and small quantities of methyl cinnamate, cineole, and other 
terpenes), tannins, camphor, flavonoids, triterpene, and urolic acid. Leaves are 
diaphoretic and antiperiodic which are used in patients suffering from bronchitis, 
gastric and hepatic disorders.9 
Ocimum sanctum seed oil modulates both humoral and cell mediated immune 
responsiveness as well as it inhibits acute as well as chronic inflammation. The 
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essential oil and seed extract act by the inhibition of cyclo-oxygenase and 
lipoxygenase pathways 10. 
The existing literature on the various properties of ocimum sanctum makes it a 
potential agent for treating wide array of disease ranging from mild illness to severe 
conditions.11 The reported properties of tulsi includes: Anti-oxidant, Expectorant, 
Analgesic, Antidiabetic, Cardio protective, Immunomodulatory, Hypolipidemic, 
Antistress agent, Diaphoretic, Antifertility, and Anticancer etc.12 
In a clinical study done by Hosadurga R et al in (2015)12 evaluated the effect 
of 2% ocimum sanctum in the treatment of experimentally induced periodontitis in 
rats and found that ocimum sanctum reduces inflammatory load, it proves to be a 
better adjunct to conventional mechanical debridement.13 
As human studies related to the efficacy of tulsi as local drug delivery in the 
treatment of chronic periodontitis is lacking. This clinical study was planned to 
evaluate the efficacy of 10% tulsi gel in the treatment of chronic periodontitis as an 
adjunct to scaling and root planing. 
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AIM 
            To evaluate the efficacy of locally delivered 10% Tulsi gel as adjunct to 
scaling and root planing as compared to scaling and root planing alone for the 
treatment of chronic periodontitis through clinical parameters and microbiological 
assays. 
OBJECTIVES 
 To prepare 10 % Tulsi gel using Tulsi extract and chitosan as polymer 
 To assess the efficacy of 10% Tulsi gel as an adjunct to scaling and root 
planning  
 To investigate the qualitative changes of Porphyromonas gingivalis in 
response to 10% Tulsi gel using  qualitative PCR 
 To compare the test and control group in both clinical and microbiological 
parameters. 
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Periodontitis is an inﬂammatory disease of the supporting tissues of the teeth 
caused by specific microorganisms or groups of specific microorganisms resulting in 
progressive destruction of the periodontal ligament and alveolar bone with pocket 
formation, recession, or both.1 
NON SURGICAL PERIODONTAL THERAPHY - MECHANICAL 
Nonsurgical periodontal therapy (NSPT) is the cornerstone of periodontal 
therapy and the first recommended approach to the control of periodontal infections. 
It is also known as “Cause-related therapy2. 
Ramfjord S et al (1975)14 evaluated the effects of three modalities 
(subgingival curettage, modified Widman flap surgery, and pocket elimination) of 
periodontal treatment on 82 patients. The follow up period were about 1 to 5 years. 
On checking the clinical parameters CAL improved at the end of 3 years in 
subgingival curettage group whereas at the end of the study there was no significant 
difference among three modalities of treatment. 
Hardy J et al in (1982)15 compared the syringe and blunt hypodermic needle 
for its penetrability in the periodontal pockets. Disclosing agents were used along 
with irrigating solution either at the gingival margin or deep in to the pocket by either 
of the two devices. They concluded that deep irrigation with hypodermic needle 
showed better results  
Cercek JF et al in (1983)16 conducted a study on 7 patients with chronic 
periodontitis to monitor and compare the healing events after homecare plaque control 
and clinical instrumentation. The clinical parameters were checked at 3, 5 and 
9months, they found out that significant improvements in periodontal pockets cannot 
be achieved with homecare alone, and concluded that combined therapy of homecare 
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plaque control and clinical instrumentation are imperative for successful periodontal 
healing. 
McNabb H et al (1992)17 conducted a study to evaluate the effect of 
Supragingival plaque control. A total of 6 patients with deep periodontal pockets were 
recruited to the study. At 3rd week of 12 weeks evaluation it was found that gram 
positive organisms increased while gram negative and spirochetes decreased. 
Cobb CM in (1996)18 reviewed the effect of mechanical non - surgical therapy 
and suggested that mechanical non- surgical therapy may eliminate microbial toxins 
and also when compared to manual instrumentation the power driven ultrasonic 
instrumentation showed better results. 
Konopka Ł et al in (2012)19 determined the amount of immune and  
inflammatory mediators following scaling and root planing in patients with chronic 
periodontitis. A total of 51 subjects were recruited for the study. Following SRP the 
clinical parameters recorded and GCF samples were collected at 1st and 4th week and 
found that short term effects of SRP have significantly reduced clinical parameters 
and decreased inflammatory mediators (IL – 1 beta, IL-8 and mmp8). 
LOCAL DRUG DELIVERY AGENTS: 
CHLORHEXIDINE 
Jain M et al in (2013)20 conducted a study to evaluate the efficacy of 
chlorhexidine gel as an adjunct to SRP in the treatment of chronic periodontitis. A 
total of 30 patients (60 sites) with 5 to 7 mm of probing depth. 30 sites treated with 
SRP alone and 30 sites treated with SRP and chlorhexidine gel. Clinical parameters 
were recorded at baseline, 6 weeks, 3months, and 6months, and found that from 
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baseline to a period of 6 months, significant difference was found between test and 
control group for PD, CAL, PI and BOP, P value being PD (P = 0.002), CAL index 
(P = 0.014), respectively. They concluded that chlorhexidine gel can be used as an 
adjunct to SRP in the treatment of periodontitis. 
Vadiati Saberi B et al in (2017)21 investigated the effect of 0.2% 
chlorhexidine as a topical supplementation in the treatment of chronic periodontitis. 
62 sites received SRP alone and another 62 sites received SRP with 0.2 % 
chlorhexidine gel. Clinical parameters were checked at 2, 3 and 6 months and they 
found that SRP with 0.2 chlorhexidine gel group showed significant reduction in 
clinical parameters when compared to SRP alone group. 
TETRACYCLINE 
Panwar M, Gupta SH in (2011)22 assessed the role of tetracycline in the 
treatment of periodontal disease. A total of 30 patients with chronic periodontitis 
having 5mm of probing depth were recruited for the study. Group A (SRP alone), 
Group B (SRP with tetracycline fiber). They recorded the clinical parameters at 
baseline, 60days, and 90days and found that both the groups showed improvements in 
clinical parameters. Compared to Group A, Group B shoed better results. 
Suchetha A et al in (2014)23 designed a study to compare the efficacy of 
locally delivered tetracycline fibers and povidone iodine. 30 patients were grouped 
into tetracycline group and povidone iodine group. Clinical parameters were checked 
at baseline and 3months.the intergroup comparison showed statistically significant 
result in tetracycline group with better improvements in clinical parameters than 
povidone iodine group. 
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DOXYCYCLINE  
Maurizi et al in (2012)24 conducted a study to evaluate the effects of slow 
release doxycycline gel adjunct to SRP in patients with persistent periodontitis. The 
results showed that local administration of slow release doxycycline provided short 
term benefits in controlling inflammation and deep pockets in treated patients. 
MINOCYCLINE 
Pandit N et al in (2013)25 conducted a study to evaluate and compare the 
effects of Minocycline microspheres and 25% Metronidazole gel when used as an 
adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis, 
showed significant reductions in PPD and CAL at 1 and 3 months when compared to 
baseline values (P < 0.001). At 3 months, sites treated with minocycline showed an 
additional reduction in PPD of 0.85 ± 0.03 mm, significantly greater than SRP alone. 
And concluded that treatment with Minocycline microspheres and Metronidazole gel 
improve PPD and CAL in patients with periodontitis compared to SRP alone. 
METRONIDAZOLE 
Greenstein G et al in (1998)26 reported that there was reduction in probing 
depth when the treatment were combined (metronidazole gel and routine SRP). They 
observed it over a period of 9months. 
Mohamed Haris PM et al in (2017)27 reviewed the role of metronidazole in 
the treatment of periodontitis and concluded that metronidazole alone may not be used 
as monotherapy, better it is used as adjunct to enhance the conventional therapy. 
Nurul Adha et al in (2017)28 conducted an invitro study to determine the 
efficacy of chitosan based metronidazole gel in inhibiting the growth of 3 periodontal 
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bacteria (A.actinimycetemcomitans, P.gingivalis, and F.nucleatum). Metronidazole 
gel were formulated with chitosan at 0.125%, 0.25%, 0.5%, 1%, 2% and they reported 
that in all the concentrations the MIC is found to be more than 22mm of inhibition 
zone. At 2% concentration the MIC are better when compared to other concentrations, 
chitosan without metronidazole gel does not show antibacterial activity. They 
concluded that chitosan can be used as a medium to deliver other drugs. 
CLARITHROMYCIN GEL  
Agarwal E et al in (2012)2 9 evaluated the efficacy of 0.5 % clarithromycin gel 
as a local drug delivery agent adjunct to SRP in the treatment of chronic periodontitis 
in smokers. 61 patients grouped into 2 (control and test group) and clinical parameters 
recorded at baseline 1, 3, and 6 months.  They reported that at the end of 6 months the 
clinical parameters significantly improved in 0.5 % clarithromycin gel group when 
compared to SRP alone group. 
FIBROBLAST GROWTH FACTOR  
Nakahara T et al in (2003)30 conducted a study to evaluate the effects of 
sandwich membrane and controlled release basic fibroblast growth factor from the 
same. They observed over a period of 4 weeks and found that sandwich membranes 
had better regeneration of periodontal tissues. 
Qi Hui et al in (2018)31 reviewed the FGF formulations and its clinical 
applications and concluded that FGF is effective and safe in promoting better 
environment for wound healing. 
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HERBAL LOCAL DRUG DELIVERY AGENTS 
Herbal drugs have long era of use and good patient tolerance as well as better 
public acceptance. Herbal drugs are renewable source which is our only hope for 
sustainable supplies of cheaper medicines for the worlds growing population.10 
Plethora of studies are available to show the potential benefits of herbal products and 
their medicinal properties in treating both periodontal and general oral health. 
CURCUMIN (Curcuma longa) 
Nagasri M et al in (2015)32 evaluated the efficacy of curcumin as an adjunct 
to scaling and root planing in the treatment of chronic periodontitis patients. A total of 
30 patients grouped in to 2(SRP alone and SRP with curcumin gel) with ≤5mm 
probing depth were enrolled to the split mouth design study, clinical and 
microbiological parameters were checked at baseline and 4th week. They found that 
SRP and curcumin gel group showed reduced clinical and microbiological parameters 
when compared to control group. 
NEEM (Azadirachta indica) 
Ajay Bhambal et al in (2011)33conducted a study to compare the efficacy of 
neem stick to that of tooth brush. They enrolled 30 patients grouped into neem and 
tooth brush group. After scaling they assessed gingival index and plaque index at 
baseline and at 3rd week and reported that no significant difference between two 
groups. They concluded that chewing neem stick can be advocated in areas where the 
facilities for complete oral health is limited 
Vennila K et al in (2016)34conducted a study to evaluate the efficacy of 10 % 
Neem gel as an adjunct to scaling and root planing in the treatment of chronic 
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periodontitis patients. A total of 20 patients with 40 sites having probing depth ≤5mm 
were recruited to the study (split mouth design) and they assessed the clinical 
parameters and microbiological assay (P.gingivalis using PCR) at baseline, on 7th day 
and 21st day and found that clinical parameters significantly improved at neem sites 
with reduced P.gingivalis counts. 
GUAVA (Psidium guajava) 
Y Sunaina Shetty et al in (2018)35assessed the inhibitory effect of guava 
extract on P.gingivalis and A. actinomycetemcomitans and found that A. 
actinomycetemcomitans are more susceptible to guava extract than P.gingivalis does. 
They concluded that guava extract may be used as a potential therapeutic agent in 
treating periodontitis. 
ALOE VERA (Aloe barbadensis) 
Bhat G et al in (2011)36 conducted a study on 15 patients (with minimum of 
5mm probing depth) to assess the clinical effects of Aloe Vera gel in the treatment of 
chronic periodontitis after SRP.PI,GI and PPD were recorded at baseline, 1st month, 
3rd month. They found that there were significant improvements in the clinical 
parameters in Aloe vera group and concluded that Aloe Vera can be used as local 
drug in treating periodontal pockets. 
Harjit Kaur Virdi et al in (2012)37assessed the efficacy of locally delivered 
aloe vera gel as an adjunct to SRP in the treatment of chronic periodontitis. They 
reported that at 6 weeks significant improvements in the GI and PPD in SRP- Aloe 
Vera group showed better results than SRP alone group (P < 0.0001). 
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POMOGRANATE (Punica granatum). 
Kote S et al in (2011)38 studied the efficacy of pomegranate juice on dental 
plaque microorganisms. A total of 30 subjects participated in the study. Plaque 
samples were collected before and after rinsing 30ml of pomegranate juice. Results 
showed significant reduction in colony forming unites of streptococci (23%) and 
lactobacilli (46%). And concluded that pomegranate can be used as potential 
alternative to treat plaque bacteria. 
Prasad D et al in (2014)39 reviewed the potential use of Punica granatum in 
the treatment of periodontal disease and concluded that Punica granatum possess 
antibacterial, antiviral, antioxidant, anti-inflammatory, wound healing, probiotic 
properties and it could prove truly as a “Pharmacy unto itself” for the treatment of 
periodontal disease 
GREEN TEA (Green Tea Catechin) 
Chatterjee A et al in (2012)40  reviewed the use of green tea in periodontal and 
general health and concluded that Continuous use of green tea catechin on a daily 
basis may be a useful and practical method for the prevention of periodontal disease, 
but should be carried out with caution to avoid side-effects. 
Deshpande N et al in (2012)41 evaluated the efficacy of green tea on 
periodontal status. 42 systemically healthy individuals were grouped into 3 (SRP 
alone, SRP with green tea and green tea alone). The clinical parameters were recorded 
at baseline, 3 and 6 months. All the three groups showed significant (P < 0.01) 
improvement in all the parameters measured at baseline and compared at 3 and 6 
months. They concluded that green tea has beneficial effects on periodontal disease 
both prophylactically and therapeutically. 
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GARLIC (Allium sativum L) 
Shetty S et al in (2013)42 conducted an invitro study to evaluate the 
antimicrobial efficacy of garlic extract on periodontal pathogens. They prepared both 
Ethanolic (EGE) and aqueous extract (AGE) and assessed the antiproteolytic activity 
of both EGE and AGE on P.gingivalis. They reported that AGE has better effect on 
P.gingivalis than EGE. Also it has better antimicrobial action against periodontal 
pathogens.  
ONION (Allium cepa L.) 
Jung-Haeng Kim in (1997)43 studied the antimicrobial activities of onions on 
the important bacteria causing dental caries and periodontitis. And found that onion 
extract showed bactericidal activity on all the tested bacteria. The activity stayed even 
after 48hours. They concluded that the antibacterial component of onion can be used 
potentially in treating dental caries and periodontal disease. 
TERMINALIA CHEBULA 
Esther P S et al in (2017)44conducted a clinical study to evaluate the efficacy 
of Terminalia chebula in 80 patients with generalized chronic gingivitis. The patients 
were grouped into group I (oral prophylaxis alone) group II (oral prophylaxis along 
with Chebula as gingival massage powder) clinical parameters were checked at 
baseline and at 1 month. They found that group II showed significant reduction in 
clinical parameters from baseline to 1 month and concluded that Chebula can be used 
as a plaque controlling agent. 
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MISWAK (Salvadora persica) 
Dahiya P et al in (2012)45 reviewed various pharmacological and therapeutic 
aspects of Miswak and compared it with that of modern tooth brush in controlling 
dental plaque, and concluded that Miswak can be used as an oral hygeine aid. 
TULSI AS LOCAL DRUG DELIVERY AGENT 
Singh S et al (2007)46 conducted an animal study to determine the biological 
activities of ocimum sanctum oil and found that it possessed significant anti-
inflammatory, antipyretic, analgesic, antiarthritic, anticoagulant, hypotensive, chemo 
preventive and antibacterial activities and concluded that α-Linolenic acid, was 
responsible for the major biological activities of ocimum sanctum oil 
Gupta D et al (2014)47 conducted a study to assess the antiplaque effects of 
ocimum sanctum mouth wash and compared to that of gold standard chlorhexidine 
mouth wash and concluded that ocimum sanctum mouth wash has equal effect in 
reducing gingival inflammation and plaque formation with minimal side effects 
Gaur J et al (2015)11 conducted a randomized controlled trial with 30 patients 
grouped into two ( 15 each),  among which one group received SRP and ocimum 
sanctum as intrapocket irrigant and the other group received SRP and 0.2% 
chlorhexidine as intrapocket irrigant and they recorded preoperative and post-
operative clinical parameters at baseline and 30days. They concluded that 4% ocimum 
sanctum showed equal effects in reducing periodontal indices like chlorhexidine does 
but with minimal side effects. 
Prabhakar AR et al (2015)48 conducted a study to evaluate the efficacy of 
Tulsi as an intra canal medicament in primary molars compared to that of sodium 
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hypochlorite and concluded that Tulsi had better effect due to the presence of eugenol 
as its one of active component which is less toxic than sodium hypochlorite 
Hosadurga R et al (2015)12 evaluated the effect of 2% ocimum sanctum in the 
treatment of experimentally induced periodontitis in rats and found that the 2% 
ocimum sanctum gel showed 33.66 % reduction in tissue inflammation during its 
peak activity at 24 hours, and showed significant reduction in PD and GI, but it did 
not show bone regeneration on the long run hence concluded that 2% ocimum 
sanctum can be used as an adjunct to improve the effects of conventional periodontal 
therapy. 
Mallikarjun et al (2016)13 conducted an invitro study to assess the 
antimicrobial efficacy of Tulsi leaf on periodontal pathogens like Aggregatibacter 
actinomycetemcomitans, Prevotella intermedia, and Porphyromonas gingivalis with 
doxycycline as standared. They found that Tulsi at 5% and 10% showed better 
inhibition zones against Aggregatibacter actinomycetemcomitans than smaller 
inhibition zones against Prevotella intermedia, and Porphyromonas gingivalis and 
concluded that Tulsi can be used as an effective and affordable adjunct to the 
conventional periodontal therapy. 
Ahmed SI et al (2017)49 evaluated the efficacy of Tulsi extract and honey 
mouth rinses in reducing the s.mutans when compared with 0.2% chlorhexidine 
mouth rinse, a total of 55 individuals were enrolled in this study and grouped in to 
chlorhexidine, Tulsi and honey respectively. They assessed the OH status of 
individuals before and after mouth rinse and the MIC of all the three in reducing 
s.mutans  and reported that both Tulsi and honey significantly reduced s.mutans but 
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not as effective as 0.2% chlorhexidine, so Tulsi and honey mouth rinses can be used 
in areas where in the people are inaccessible to chlorhexidine. 
Jayanti I et al (2018)50 conducted an invitro study similar to that of 
Mallikarjun et al in 2016 to assess the antimicrobial activity of ocimum sanctum 
against Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis and 
reported that the 8% concentration of the tulsi extract showed maximum inhibitory 
zone against A. actinomycetemcomitans and P. gingivalis (40.10 ± 0.90, 33.79 ± 1.82 
mm), followed by the 6, 4, and 2% concentrations. The 0.2% chlorhexidine, which 
was the positive control, had 39.80 ± 1.24 and 32.28 ± 1.28 mm inhibitory zone and 
suggested that 8% tulsi extract can be used as an adjunct to conventional therapy in 
the treatment of periodontal disease. 
Amrita Parida1 et al (2018)51 evaluated the antimicrobial efficacy of ocimum 
sanctum against oral pathogens such as Prevotella intermedia, Streptococcus mutans, 
Candida albicans, Lactobacillus acidophilus, Streptococcus mitis, and 
Peptostreptococcus using agar well diffusion and broth dilution method with 
chlorhexidine as control and found out that inhibition zone of 6mm and 7.33mm was 
found in p.intermedia and s.mitis. The inhibitory zone of peptostreptococus was 
similar for both tulsi and chlorhexidine. They concluded that ocimum sanctum can be 
used in adjunct to other products used to maintain oral hygiene. 
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                A randomized, split mouth, controlled clinical study was conducted to 
evaluate the effectiveness of 10% Tulsi gel in the non-surgical treatment of chronic 
periodontitis compared to SRP alone. The protocol was reviewed and approved by 
institutional ethical board members. The study related procedures were explained to 
the patients before they signed an informed consent form. A total of 60 sites was 
selected from 30 subjects with moderate to severe periodontitis in the age group of 
18-65 years were enrolled from the outpatient attending the Department of 
Periodontics, Vivekananda Dental College for Women, Elayampalayam, Namakkal, 
Tamil nadu. Based on the below mentioned inclusion and exclusion criteria. 
Inclusion criteria:  
1. Age limit of 18-65 years of both the gender. 
2. Probing pocket depth (PPD) of 5-6 mm bilaterally as examined with 
Williams probe 
3. Systemically healthy subjects. 
4. Patients who are willing to participate in the study. 
Exclusion criteria: 
1. Patients with the history of periodontal therapy within 6 months prior to 
the study. 
2. Chronic use of antibiotics/ anti- inflammatory drugs 3 months prior to 
the study 
3. Routine use of mouthwash or other plaque controlling agents 
4. Diabetic patients or other immunocompromised patients 
5. Any form of tobacco users, alcohol users. 
6. Known history of allergic to drugs  
7. Pregnant and lactating women. 
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8. Pathologic migration / tooth under traumatic occlusion. 
STUDY DESIGN: 
It’s a split mouth study. 30 Patients who met the above mentioned criteria 
were recruited to the study. A total of 60 sites were randomly divided into control and 
experimental sites as follows. 
Group I Control:  having 30 Sites treated with Scaling and Root Planing alone 
Group II Experimental: having 30 Sites treated with Scaling and Root Planing 
followed by the injection of 10%Tulsi Gel.  
CLINICAL PARAMETERS: 
           The following variables were measured at baseline and at 21st day. 
1. Plaque index (PI) 
2. Gingival index (GI) 
3. Sulcus bleeding index (SBI) 
4. Probing pocket depth (PPD) 
5. Relative attachment level (RAL) 
1. Plaque index: (Turskey et al modification of Quigley Hein index, 1970) – 
TQHPI52. 
            With the TQHPI, mesial, distal and mid surfaces of facial and lingual 
aspectswere scored.  
Scoring was as follows: 
0- No plaque/debris. 
1- Separate flecks of plaque at the cervical margin of the tooth. 
2- A thin continuous band of plaque (up to 1 mm) at the cervical margin 
of the tooth. 
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3-  A band of plaque wider than 1 mm but covering less than one third 
of the crown of the tooth. 
4 - Plaque covering at least one third but less than two thirds of the 
crown of the tooth. 
0  - Plaque covering two thirds or more of the crown of the tooth. 
2. Gingival index: (Loe and Silness 1964)53 
            The Gingival Index was created for the assessment of the gingival condition 
and records qualitative changes in the gingiva. It scores the marginal and 
interproximal tissues separately on the basis of 0 to 3. The criteria are: 
   0- Normal gingiva. 
1- Mild inflammation – slight change in color and slight edema but no 
bleeding on probing. 
2-  Moderate inflammation – redness, edema and glazing, bleeding on 
probing. 
3- Severe inflammation – marked redness and edema, ulceration with 
tendency to spontaneous bleeding. 
The scores of the four areas of the tooth can be summed and divided by four to give 
the GI for the tooth.  A score from 
                    0.1-1.0 - Mild inflammation. 
                   1.1-2.0 - Moderate inflammation  
                   2.1-3.0 - Signifies severe inflammation. 
3. Sulcus bleeding index: (Muhlemann and Son, 1971)54 
             The criteria for scoring are as follows: 
                     0 - Healthy looking papillary and marginal gingiva, no bleeding on 
probing. 
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                     1 - Healthy looking gingiva, bleeding on probing. 
                     2 - Bleeding on probing, change in color, no edema. 
                     3 - Bleeding on probing, change in color, slight edema. 
                     4 - Bleeding on probing, change in color, obvious edema. 
                     5 - Spontaneous bleeding, change in color, marked edema. 
             Four gingival units are scored systematically for each tooth: the labial and 
lingual marginalgingival (M units) and the mesial and distal papillary gingival (P 
units). Scores for these units are added and divided by four. Adding the scores of the 
undivided teeth and dividing them by the number of teeth can determine the sulcus 
bleeding index. 
4. Probing pocket depth (PPD) was recorded using Williams probe. 
5. Relative attachment level (RAL) - Relative distance between base of the 
pocket and fixed reference point on the stent for assessing clinical attachment 
gain or loss. 
PREPARATION OF TULSI EXTRACT  
The fresh leaves of tulsi were procured from Ayurveda dispensary, and 
approved by a botanist from Department of  Botany, Vivekananda college of arts and 
science for women, Elayampalayam, Namakkal, as shown figure – 1. The leaves were 
cleaned using distilled water and shade dried. The dried leaves were stored in clean 
air tight container until further use. Using Soxhlet apparatus tulsi extract was prepared 
by the following manner, asshown in figure – 2, 100gms of dried tulsi was placed in 
the thimble of Soxhlet apparatus. 500ml of double distilled water was used as solvent. 
The extraction was continued till solvent was seen in the thimble, further the extract 
was placed in a digital water bath till a dark green residue was obtained. The extract 
was stored in a clean airtight container until further use. 
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PREPARATION OF 10% TULSI GEL BY SIMPLE DISPERSION METHOD: 
The formulation as done in JSS college of Pharmacy, Ooty. Ten percentage 
tulsi gel were prepared in the following manner. Chitosan was soaked In 100 ml of 
double distilled water containing 0.10% W/V Sodium benzoate, 0.10ml of lactic acid 
was added to neutralize the pH. 10ml 0f tulsi extract was added to the mixture 
(aqueous extract prepared from, Vivekananda College of arts and science for women). 
The drug solution were placed in blender as shown in figure- 4 until a homogenized 
mixture was obtained. The control gel was prepared in the same manner without 
adding the tulsi extract. The prepared gel looks like dark green in color as shoe in 
figure – 6. This gel was stable over a period of 9 months. Slight pH changes were 
noted and corrected. In the same manner the tulsi gel at other concentrations were 
prepared (2%, 4%, and 15%) to know the exact concentration of tulsi at which the 
maximum inhibitory effect was obtained. 
EVALUATION OF ANTI – MICROBIAL ACTIVITY OF PREPARED TULSI 
GEL.  
The antibacterial activity of prepared tulsi gel at various concentrations were 
done by using MHA (Muller Hinton agar) media. Under strict aseptic conditions, the 
MHA hot media as poured into Petri plates and allowed it to cooldown to room 
temperature. Plaque samples were inoculated into the agar using streak method 
following which the plates were incubated for 24hours at 37 degree Celsius, as shown 
in figure - 7 Then five wells were cut at a distance of 25mm from each well for each 
concentration (2 %, 4%, 10% and 15%) and one as control (plain gel prepared from 
chitosan polymer and the gels were placed at respective wells. 
Materials and methods 
 
22 
 
The plates were then inoculated at 37 degree Celsius for 24hours at incubator, 
following 24hours of incubation, the inhibition zones were measured using Vernier 
caliper. Among the various concentrations of tulsi gel and control, the 10% 
concentration showed maximum inhibitory zone of 16mm against tested pathogens 
from the subgingival plaque sample, as shown in figure - 8 which is in accordance 
with the study done by Mallikarjun et al (2016)13. 
CLINICAL PROCEDURE; 
Selected sites were randomly grouped into experimental group and control 
group. The experimental group sites received scaling and root planing along with 10% 
Tulsi gel. The control group sites received scaling and root planing only. 
            After assessing the clinical parameters, subgingival plaque samples were 
collected. The samples were then transferred to the vials and sent for microbiological 
assessment. Scaling and root planing were performed. Then Tulsi gel was inserted 
deep into the periodontal pockets using blunt needle at the experimental site. Then at 
the end of 21 days clinical parameters were again recorded and subgingival plaque 
samples were collected and sent for microbiological assessment. 
MICROBIOLOGICAL ASSESSMENT; 
Sub-gingival plaque sample were collected using sterile curette. The sample 
were suspended in a sterile tube and stored at -800c until analysis. Microbiological 
samples were taken at baseline and on 21stday. The plaque samples were assessed for 
estimating qualitative PCR assay to assess Porphyromonas gingivalis.  
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APPENDIX – 1 
 
Post therapy instructions 
 
 Report immediately on development of any untoward reactions like pain, 
swelling, bleeding, and drug allergies. 
 Should avoid intake of any hard & hot foods, not to disturb the operated area 
with tongue for 3days. 
 Report if dressing is dislodged. 
 Avoid brushing the treated area from the day of therapy. Use cotton applicator 
to gently clean the area and resume gentle brushing with soft brush and 
coronally directed roll technique. 
 Avoid the use of medications & mouth rinses. 
 To report as per schedule. 
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APPENDIX – 1I 
PROFORMA 
 
Name:                                                   Date:  
Age/Sex:                                                               Op number: 
Address:   
 
HISTORY 
 
 
Chief complaints: 
 
Past Medical history: 
 
Past Dental history: 
 
Personal History: 
 
Intraoral Examination: 
 
 
Investigations: 
  
 Radiographics: 
 
 Blood investigations: 
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CLINICAL EXAMINATION 
 
I-BASELINE:  
MODIFIED QUIGLEY HEIN PLAQUE INDEX:(Turesky et al 1970) 
 
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
              
 
              
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
              
 
Score: 
 
Interpretation: 
 
GINGIVAL INDEX :( Loe Silness 1963) 
      
16 12 24 36 32 44 
      
 
Score: 
 
Interpretation: 
 
GINGIVAL BLEEDING INDEX(Ainamo &Bay 1975) 
 
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
              
 
              
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
              
No of sites:                                             Percentage of sites: 
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PROBING DEPTH AND CLINICAL ATTACHMENT LEVEL: 
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PD                 PD 
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PD                 PD 
CAL                 CAL 
 
 
DIAGNOSIS: 
 
Probing Pocket depth (mm) & Relative attachment Level 
No Study Group  
        I 
Study Group 
        II 
PD   
CAL   
 
Microbiological Examination:                
  I      II 
P.gingivalis ( No of micro-organisms )   
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CLINICAL EXAMINATION 
 
II- AFTER 21 DAYS  
MODIFIED QUIGLEY HEIN PLAQUE INDEX:(Turesky et al 1970) 
 
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
              
 
              
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
              
 
Score: 
 
Interpretation: 
 
GINGIVAL INDEX :( Loe Silness 1963) 
      
16 12 24 36 32 44 
      
 
Score: 
 
Interpretation: 
 
GINGIVAL BLEEDING INDEX(Ainamo &Bay 1975) 
 
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
              
 
              
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
              
No of sites:                                             Percentage of sites: 
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PROBING DEPTH AND CLINICAL ATTACHMENT LEVEL: 
CAL                 CAL 
PD                 PD 
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PD                 PD 
CAL                 CAL 
 
DIAGNOSIS: 
 
Probing Pocket depth (mm) & Relative attachment Level 
No Study Group  
        I 
Study Group 
        II 
PD   
CAL   
 
Microbiological Examination:                
  I      II 
P.gingivalis ( No of micro-organisms )   
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INFORMED CONSENT FORM 
VIVEKANANDHA DENTAL COLLEGE FOR WOMEN 
TIRUCHENGODE 
 
DEPARTMENT OF PERIODONTICS 
Research student: Saranya.S 
 
Patient Name:       Male/female: 
Address:        Age:  
 
 
I have been explained the nature and purpose of the study in which I have 
been asked to participate. I have been given the opportunity to question about the 
study and other procedures. I hereby give the consent to be included in this study. 
 
 
 
 
 
 
Place:                                              
Date:                                                             
Signature of patient 
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தகவ᾿ஒᾺᾗைமபᾊவΆ 
விேவகானᾸதாப᾿மᾞᾷᾐவக᾿ᾥாி 
திᾞெசᾱேகாᾌ 
 
ஈᾠேநாᾼசிகிᾲைசᾺபிாிᾫ 
 
ஆᾼவாள᾽ : சரᾶயா.ேச 
 
ேநாயாளிெபய᾽:           ஆᾶ/ெபᾶ : 
ᾙகவாி:      வயᾐ : 
 
 
___________________________ ஆகிய எனᾰᾁ பாிேசாதைன பιறிய அைனᾷᾐ 
விவரᾱகᾦΆ ெதளிவாக ᾗாிᾜΆ பᾊ எᾌᾷᾐைரᾰகᾺப᾵டன. எᾹᾔைடய சᾸேதகᾱக῀ 
அைனᾷதிιᾁΆ ெதளிவான பதி᾿ அளிᾰகᾺப᾵டᾐ. எனᾐ பாிேசாதைனகᾦᾰᾁ 
ᾙᾨமனேதாᾌ சΆமதிᾰகிேறᾹ.  
 
 
இடΆ:  
ேததி:                                                            
ேநாயாளி  ைகெயாᾺபΆ 
 
APPENDIX – III 
 ARMAMENTARIUM 
 
 Gloves 
 Mouth mask 
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 Patient apron 
 Chair apron 
 Head cap 
 Sterile cotton rolls 
 Gauze 
 Saline  
 Kidney tray  
 Betadine  
 Lignocaine  
 Syringe  
 Mouth mirror 
 Straight probe 
 Explorer  
 UNC – 15 probe  
 Tweezer  
 Tissue holding forceps  
 Hu – Friedy Gracey Curettes 
 Ultrasonic Scalers 
 10% Neem chip 
 Scissors  
 Coe pack 
MATERIALS AND INSTRUMENTS FOR MICROBIOLOGICAL STUDY: 
 Pre weighed 0.5 ml sterile saline 
 Eppendorf tubes 
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 Sterile curettes 
 Storage  containers 
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Preparation of Tulsi gel 
 
Raw Tulsi                                                        Soxhlet apparatus 
 
                 FIGURE – 1                                                         FIGURE – 2 
 
 
Remi Blender                                                         Polymer without Tulsi extract 
                                
                    FIGURE – 3                                                           FIGURE - 4 
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Prepared 10% tulsi gel.                                                Prepared gel in blunt cannula. 
               
                              FIGURE -5                                                          FIGURE-6 
 
Antimicrobial evaluation of prepared gel. 
 
                     Culturing                                                              MIC 
               
                     FIGURE -7                                                      FIGURE – 8 
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Clinical cases 
Armamentarium Required for NSPT 
 
FIGURE – 9 
 
Clinical Case – baseline                                      Placement of 10% Tulsi  gel 
                   
                   FIGURE – 10.                                                       FIGURE – 11. 
21st day  
 
FIGURE - 12 
RESULTS
Results 
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Statistical analysis:  
The obtained results were subjected to statistical analysis. As the study is 
“split mouth design”, to compare mean values between groups paired t-test is applied. 
To compare mean values between pre-op and post-op time points also paired t-test is 
applied. To analyze the data SPSS (IBM SPSS Statistics for Windows, Version 23.0, 
Armonk, NY: IBM Corp. Released 2015) is used. Significance level is fixed as 5% (α 
= 0.05). The Normality tests Kolmogorov-Smirnov and Shapiro-Wilks tests results 
reveal that variables follow Normal distribution. Therefore, to analyze the data 
parametric methods are applied. 
Clinical evaluation:  
       No untoward reactions was reported by any patient, better patient compliance, 
healing was uneventful. All the patients reported for the postoperative review at 21st 
day without any complications. 
CLINICAL PARAMETERS: 
Plaque index (PI): 
 Plaque index as significantly reduced from baseline to 21st day at test and 
control sites. The plaque index score was 2.9667 ± 0.78798 and in 21st day 1.1517 ± 
0.73618 showed significant changes with the mean difference of 1.8150 and p-value 
of less than 0.001, as shown in table - 1 and graph -1 
Gingival index (GI): 
At baseline the gingival index was found to be 2.2600±0.68114 and it is 
reduced significantly to 1.1533±0.48109 at 21st day, the mean difference was 1.1067 
and p value of less than 0.001, as shown in table – 2 and graph – 2. 
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Bleeding index(BI): 
The sulcus bleeding index score was found to be 69.93 ± 24.507 and reduced 
at 21st day to 20.77 ± 20.638 with the mean difference of 49.167 with the p-value of 
less than 0.001, as shown in table - 3 and graph - 3 
Pocket probing depth (PPD): 
 The mean pocket probing depth was significantly reduced at 21st day from 
baseline in both test and control sites. The mean PPD was 5.20 ± 0.805 at baseline 
reduced to 3.27 ± 0.944 at 21st day in control sites and the mean PPD of test sites at 
baseline is 5.57 ± 0.817 reduced significantly to 2.37 ± 0.490 at 21st day, As shown in 
table - 4 and graph - 4. 
Relative attachment level (RAL): 
The mean relative attachment level (RAL) was reduced both in control and 
test sites. The mean relative attachment level was 5.43 ± 0.774 at baseline which is 
reduced to 3.50 ± 0.974 in control sites at 21st day and the mean relative attachment 
level at baseline in test sites are found to be 5.47 ± 0.681 and it is reduced to 2.57 ± 
0.568 at 21st day, as depicted in table – 5 and graph – 5. 
Microbiologicalassessment: 
The complete or near complete absence of Porphyromonas gingivalis at almost 
all the sites at 21st day in test group (at baseline about 66.7% (++) of P.gingivalis were 
present which was completely absent at 21st day and 13.3% of (+++) P.gingivalis 
were present at baseline and completely absent at 21st day as shown in table – 8 and 
graph - 6).   
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  But in control sites Porphyromonas gingivalis was present in some sites post 
operatively at 21st day (at baseline about 60% of (++) P.gingivalis were present which 
was reduced to 3.3% at 21st day and 6.7 % of (+++) P.gingivalis were present at 
baseline and completely absent at 21st day as shown in table – 8 and graph - 6). 
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TABLE 1: COMPARISON OF MEAN CHANGES IN PLAQUE INDEX 
BETWEEN BASELINE AND 21ST DAY 
 
 
Plaque index N Mean Std. Dev Mean diff SE t-value p-value 
Baseline 30 2.9667 0.78798 
1.8150 0.1825 9.944 <0.001 
21st day 30 1.1517 0.73618 
 
 
 
TABLE 2: COMPARISON OF MEAN CHANGES IN GINGIVAL INDEX 
BETWEEN BASELINE AND 21ST DAY 
 
 
Gingival index N Mean Std. Dev Mean diff SE t-value p-value 
Baseline 30 1.1533 0.68114 
1.1067 0.1411 7.844 <0.001 
21st day 30 2.2600 0.48109 
 
 
TABLE 3: COMPARISON OF MEAN CHANGES IN BLEEDING INDEX 
BETWEEN BASELINE AND 21ST DAY 
 
 
 
Bleeding index N Mean Std. Dev Mean diff SE t-value p-value 
Baseline 30 69.93 24.507 
49.167 5.507 8.928 <0.001 
21st day 30 20.77 20.638 
 
 
TABLE 4: INTERGROUP COMPARISON IN MEAN PROBING DEPTH 
AT BASELINE AND 21ST DAY 
 
 
Group Probing depth  N Mean Std. Dev Mean diff SE t-value p-value 
Group-A 
Baseline 30 5.20 0.805 
1.933 0.179 10.802 <0.001 
21st day 30 3.27 0.944 
Group-B 
Baseline 30 5.57 0.817 
3.200 0.155 20.696 <0.001 
21st day 30 2.37 0.490 
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TABLE 5: INTERGROUP COMPARISON IN MEAN RELATIVE 
ATTACHMENT LEVEL AT BASELINE AND 21ST DAY 
 
 
Group Attachment loss N Mean Std. Dev Mean diff SE t-value p-value 
Group-A 
Baseline 30 5.43 0.774 
1.933 0.179 10.802 <0.001 
21st day 30 3.50 0.974 
Group-B 
Baseline 30 5.47 0.681 
2.900 0.162 17.953 <0.001 
21st day 30 2.57 0.568 
 
TABLE 6: COMPARISION OF MEAN VALUES CHNAGES IN 
PROBING DEPTH USING PAIRED T - TEST  
 
 
Time Probing depth N Mean Std. Dev Mean diff SE t-value p-value 
Baseline Group-A 30 5.20 0.805 
0.367 0.227 1.613 0.118 
Group-B 30 5.57 0.817 
21st day Group-A 30 3.27 0.944 
0.900 0.222 4.062 <0.001 
Group-B 30 2.37 0.490 
 
 
TABLE 7: COMPARISION OF MEAN VALUES CHNAGES IN 
RELATIVE ATTACHMENT LOSSUSING PAIRED T - TEST  
 
 
 
Time Attachment loss N Mean Std. Dev Mean diff SE t-value p-value 
Baseline Group-A 30 5.43 0.774 
0.033 0.155 0.215 0.831 
Group-B 30 5.47 0.681 
21st day Group-A 30 3.50 0.974 
0.933 0.214 4.360 <0.001 
Group-B 30 2.57 0.568 
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TABLE 8: CROSS TABLE FOR QUALITATIVE CHANGES OF 
P.GINGIVALIS AMONG THE GROUPS 
 
Time  Micro-assessment 
Group-A Group-B 
N  N  
Baseline + 10 33.3 6 20.0 
++ 18 60.0 20 66.7 
+++ 2 6.7 4 13.3 
Total 30 100.0 30 100.0 
21st day Nil 17 56.7 24 80.0 
+ 12 40.0 6 20.0 
++ 1 3.3 0 0.0 
Total 30 100.0 30 100.0 
 
 
 
TABLE 9: CROSS TABLE FOR QUALITATIVE CHANGES OF 
P.GINGIVALIS –MICROASSESSMENT IN GROUP A 
 
Micro-assessment 
Baseline 
+ ++ +++ Total 
N % N % N % N % 
21st day Nil 7 70.0% 10 55.6% 0 0.0% 17 56.7% 
+ 3 30.0% 8 44.4% 1 50.0% 12 40.0% 
++ 0 0.0% 0 0.0% 1 50.0% 1 3.3% 
Total 10 100.0% 18 100.0% 2 100.0% 30 100.0% 
 
 
 
 
TABLE 10: CROSS TABLE FOR QUALITATIVE CHANGES OF 
P.GINGIVALIS - MICRO ASSESSMENT IN GROUP B 
 
Micro-assessment 
Baseline 
+ ++ +++ Total 
N % N % N % N % 
21st day Nil 6 100.0% 18 90.0% 0 0.0% 24 80.0% 
+ 0 0.0% 2 10.0% 4 100.0% 6 20.0% 
Total 6 100.0% 20 100.0% 4 100.0% 30 100.0% 
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GRAPH – 1: COMPARISON OF MEAN CHANGES IN PLAQUE 
INDEX BETWEEN BASELINE AND 21ST DAY 
 
 
GRAPH – 2: COMPARISON OF MEAN CHANGES IN GINGIVAL 
INDEX BETWEEN BASELINE AND 21ST DAY 
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GRAPH – 3: COMPARISON OF MEAN CHANGES IN BLEEDING 
INDEX BETWEEN BASELINE AND 21ST DAY 
 
 
GRAPH – 4: INTERGROUP COMPARISON OF MEAN CHANGES IN 
PROBING DEPTH BETWEEN BASELINE AND 21ST DAY 
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GRAPH – 5: INTERGROUP COMPARISON OF MEAN CHANGES IN 
MEAN ATTACHMENT LEVEL BETWEEN BASELINE AND 21ST DAY 
 
 
GRAPH 6: QUALITATIVE CHANGES OF PORPHYROMONAS 
GINGIVALIS LEVEL AT BASELINE AND 21ST DAY – 
MICROASSESSMENT 
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Periodontal disease being multifactorial that is often instigated by 
polymicrobial flora from the subgingival environment. Though many periodontal 
pathogens are said to be involved in initiation of periodontal disease, Porphyromonas 
gingivalis and Aggregatibacter actinomycetemcomitans are the key periodontal 
pathogens accounted for the elaboration of the periodontal disease and destruction of 
periodontal structures.1 
Chronic periodontitis is the most common type of periodontal disease 
occurring in adults exposed to these putative pathogens. It is not an age associated 
disease rather an age related disease and can occur in any age group. The clinical 
signs and symptoms of chronic periodontitis differs from individual to individual also 
different sites of the same individual, which ranges from bleeding on probing, pocket 
formation, gingival recession, progressive attachment loss and associated bone loss. If 
left untreated, it might get severe resulting in tooth loss.2 
The traditional treatment that are followed through ages is said to be the 
mechanical debridement and it is still followed as the first choice of treatment. 
However the complex anatomy of periodontium pose a risk in the complete removal 
of plaque and calculus and makes it inaccessible to routine periodontal 
instrumentation. Which lead to the research on antibiotics and antiseptics use as an 
adjunctive therapy in eliminating the periodontal pathogens.  
Systemic antibiotics have been administered pre operatively to control 
infection or post operatively as an adjunct to mechanical debridement. Plethora of 
studies have been documented about the use of systemic antibiotics as an adjunct to 
mechanical debridement.  
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Only few drugs have been tested for their efficacy which includes 
tetracyclines, metronidazole, amoxicillin etc, Which claimed better results but always 
with the risk of developing drug resistance, increased drug reactions, adverse drug 
effects, uncertain patient compliance and inability to reach target site at adequate 
concentrations. 
These limitations of systemic antibiotic administration left the researchers to 
seek an alternative way of delivering antibiotics and antiseptics to the targeted site 
with the minimal systemic effects, higher concentrations at the GCF, better patient 
compliance which lead to the invention of the local drug delivery system.55 
In Sustained release system, 56 higher drug concentrations are achieved at the 
disease site which reduces side and toxic effects. This system is considered to have 
excellent potential as an adjunct to traditional periodontal therapy.  
 Local drug delivery systems have been classified broadly as irrigating 
systems, sustained release systems, controlled release systems, non-degradable or 
biodegradable. Based on the forms as fibers, films, chips, gels, strips, compacts.56 
among the forms we found gel system to be better as described by Rams TE et al 
(1996)56, they are semisolid preparations of drugs with adequate concentration is 
injected in the desired site with the help of blunt cannula. 
 Different types of gels are available, based on thermal changes it is divided in 
to thermo reversible and thermo irreversibe, based on degradation of polymers it is 
grouped into oleo gels, hydrogels, and nanogels and based on composition of 
polymers the types include hydroxyethyl cellulose, chitosan, Pluronic 940, corbopol 
974 of various grades. 
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         Comparing to the solid preparations, semisolid preparations like gels have better 
biocompatibility and higher mucoadhesivity which allows better adhesion of drugs to 
the mucosal cells of periodontal pocket. It decreases irritation to the host site 
compared to other solid preparations. Hence we preferred LLD in gel form for our 
study, also the polymer which we used is chitosan, a Nano polymer having 
thermoplastic and bio adhesive properties which is a primary request for prolonged 
release of the drug at periodontal pocket. 
Local drug delivery systems as local irrigation may not be more effective in 
periodontal disease management due to inadequate drug penetration into the deep 
pockets. Tetracycline fibers, metronidazole gel, chlorhexidine chips are the few 
successfully used sustained release system in periodontal therapy. Their sustained 
release, increases many fold GCF drug concentration than systemic therapy. Among 
the sustained release systems the gel forms are found to have better results 6.  
Chemical agents used in these systems are relatively expensive, not readily 
available in all parts of the world. Hence the urge for discovering new drugs that is 
promising as that of chemical agents with less toxicity, easy availability, economical. 
Medicines obtained from natural products fits into this profile.  
Plants are the primary source of medicine. Medicinal plants are considered to 
be very rich sources of secondary metabolites and oils which are of therapeutic 
importance. Use of plants as a source of medicinal value is a very old concept. 
Chinese were the first to use plants as therapeutics before 4000- 5000 B.C. In India 
use of plants as a medicine appeared in Rigveda which was written around 3500 - 
1600 B.C. Properties of plants as a source of medicine were studied detail in 
Ayurveda which is considered the foundation of all the medical sciences.55 
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Evidences about the use of various medicines obtained from plants have been 
documented in the literature. Curcumin 32, neem 33, guava 35, aloe vera 36, 
pomegranate 38, green tea 40, garlic 42, onion 43, tulsi 46 etc.  
Among the plants in the Indian subcontinent Tulsi is considered as the most 
sacred plant and is often referred as the “Holy Basil”. There is documented evidence 
of the use of Ocimum sanctum (Tulsi) as an aromatic plant in Ayuveda. Belonging to 
the family Labiatae, It grows in tropical and sub-tropical belts including India and is 
commonly seen in the Indian fields. "Tulsi" in Sanskrit means "the incomparable one" 
and hence is considered the queen of herbs. In India two forms of Tulsi are common - 
dark or Shyama (Krishna) Tulsi and light or Rama Tulsi. The former possesses greater 
medicinal value and is commonly used for worship. Other species in India include O. 
canum, O. basilicum, O. kilimandscharicum, O. ammericanum, O. camphora and O. 
micranthum. 46 
Tulsi is generally considered as an “Elixir of Life”. Traditionally tulsi has 
been employed in hundreds of different formulations for the treatment of a wide range 
of disorders involving mouth and throat, lungs, heart, blood, liver, kidney, and the 
digestive, metabolic, reproductive and nervous systems. The different part of tulsi like 
leaves, roots, flowers and stems have charismatic therapeutic potential.47 
Tulsi has been used as expectorant, analgesic, anticancer, antiasthmatic, 
antiemetic, diaphoretic, antidiabetic, antifertility, hepatoprotective, hypotensive, and 
Hypolipidemic and Antistress agent. As tulsi is a very effective in treatment of 
various medical disorders, it is also a very promising herb in management of oral 
diseases and dentistry. Tulsi leaves are quite effective in treating common oral 
infections. The tulsi leaves contains strong antibacterial like carvacrol and tetpene & 
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sesquiterpene,  b caryophylline. Chewing of Tulsi leaves, help in maintenance of oral 
hygiene. The antibacterial agent present in tulsi leaves were approved by FDA as food 
additive. Ocimum sanctum leaves contain 0.7% volatile oil comprising about 71% 
eugenol and 20% methyl eugenol.47 
 Due to significant amount of eugenol (1-hydroxyl-2 methoxy-4 allyl benzene) 
tulsi is a strong COX-2 inhibitor. This analgesic property of tulsi is utilized in 
treatment of dental and mucosal pain. The powdered tulsi leaves mixed with mustard 
oil can be used as toothpaste for tooth brushing. The powdered tulsi leaves used to 
encounter halitosis and maintaining good oral health. Massage with tulsi powder have 
reported to be highly effective in many gingival and periodontal diseases. 48 
On reviewing the excellent properties of holy basil, and scarcity of human 
studies in the literature on the use tulsi in the treatment of periodontal disease. We 
planned for an in vivo study to assess the antimicrobial effects of 10% tulsi gel in 
patients with chronic periodontitis. We prepared tulsi gel using chitosan as polymer 
and aqueous extract of tulsi as principle component at various concentrations at 2 %, 
4%, 10% and 15% at JSS pharmacy college, Ooty. 
After preparing tulsi gel at various concentration. The minimal inhibitory 
concentrations (MIC) for each concentration were done at Vivekananda College of 
arts and science, Elayampalayam to know the exact concentration of prepared gel to 
have better antibacterial action.  
The antibacterial activity of prepared tulsi gel at various concentration were 
done by using MHA (Muller Hinton agar) media. Under strict aseptic conditions, the 
MHA hot media as poured into Petri plates and allowed it to cool down to room 
temperature. Plaque samples were inoculated into the agar using streak method 
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following which the plates were incubated for 24 hours at 37 degree Celsius. Then 
five wells were cut at a distance of 25 mm from each well for each concentration (2 
%, 4%, 10% and 15%) and one as control (plain gel prepared from chitosan polymer 
and the gels were placed at respective wells. 
The plates were then inoculated at 37 degree Celsius for 24 hours at incubator, 
following 24 hours of incubation, the inhibition zones were measured using Vernier 
caliper. Among the various concentrations of tulsi gel and control, the 10% 
concentration showed maximum inhibitory zone of 16 mm against tested pathogens 
from the subgingival plaque sample, which is in accordance with the study done by 
Mallikarjun et al (2016)13 
A total of 30 patients with minimum of 5-6mm probing depth on single tooth 
on both the sides were recruited to the study with split mouth design, grouped on to 
test and control group. Test group received SPR and tulsi gel and control group 
received SRP. 
The clinical parameters such as plaque index, gingival index, sulcus bleeding 
index, pocket probing depth, relative attachment level were recorded at baseline and 
21st day. With reference from the study done by Vennila.k et al(2016)34 who has 
mentioned that the connective tissue healing is anticipated to get completed after 21 
days of periodontal treatment and they found better results hence the present study is 
planned to record postoperative values at 21st day. 
Plaque index as significantly reduced from baseline to 21st day at test and 
control sites. The plaque index score was 2.9667 ± 0.78798 and in 21st day 1.1517 ± 
0.73618 showed significant changes with the mean difference of 1.8150 and p-value 
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of less than 0.001, as shown in table - 1 and graph – 1. This is due to the antiplaque 
effect of tulsi as mentioned in the similar study done by Gupta D et al (2014)47 
At baseline the gingival index was found to be 2.2600±0.68114 and it is 
reduced significantly to 1.1533±0.48109 at 21st day, the mean difference was 1.1067 
and p value of less than 0.001, as shown in table – 2 and graph – 2. The reason for 
reduced gingival index was due to the anti- inflammatory effect of tulsi which 
contains eugenol as major component. This is accordance with the study done by 
Gaur J et al (2015).11 
The sulcus bleeding index score was found to be 69.93 ± 24.507 and reduced 
at 21st day to 20.77 ± 20.638 with the mean difference of 49.167 with the p-value of 
less than 0.001, as shown in table - 3 and graph - 3. This is due to the astringent 
effect of tulsi which reduces the inflammatory mediators and its fluids is in 
accordance with the study done by Gupta D et al (2014)47 
The mean pocket probing depth was significantly reduced at 21st day from 
baseline in both test and control sites. The mean PPD was 5.20 ± 0.805 at baseline 
reduced to 3.27 ± 0.944 at 21st day in control sites and the mean PPD of test sites at 
baseline is 5.57 ± 0.817 reduced significantly to 2.37 ± 0.490 at 21st day, As shown in 
table - 4 and graph - 4. When compared to control sites test sites showed relatively 
better results. The reason for significant change in pocket depth is due reduced 
inflammatory load after the placement of tulsi gel. This is similar to the study 
conducted by Hosadurga. R et al (2015)12. 
The mean relative attachment level (RAL) was reduced both in control and 
test sites. The mean relative attachment level was 5.43 ± 0.774 at baseline which is 
reduced to 3.50 ± 0.974 in control sites at 21st day and the mean relative attachment 
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level at baseline in test sites are found to be 5.47 ± 0.681 and it is reduced to 2.57 ± 
0.568 at 21st day. In comparing the control sites, test sites shoed better results. As 
shown in table - 5 and graph – 5, it is due to the clinical effects as mentioned in the 
other clinical parameters, which is in accordance with results documented by 
Hosadurga. R et al 12 from their study. 
Under aseptic conditions subgingival samples were collected at baseline and at 
21st day for microbiological assessment in both control and test sites. In chronic 
periodontitis sites, the most predominant and virulent pathogen among the periodontal 
bacteria is found to be Porphyromonas gingivalis. With this reference from Marsh PD 
(2003)57 the present study was planned to evaluate the qualitative changes of 
Porphyromonas gingivalis from the plaque samples of both test and control sites at 
baseline and 21st day by polymerase chain reaction (PCR). 
The reason for opting PCR for the evaluation of Porphyromonas gingivalis is 
that it requires strict anaerobic environment and special equipment’s for cultivation 
and also it pose a risk of distinguishing closely related bacteria. Keeping the bacteria 
viable and growing under strict anaerobic environment makes it technique sensitive. 
Hence the real time PCR was found to be sensitive and specific in identifying the 
bacteria in the subgingival plaque samples. 
In qualitative PCR assay, present study showed the complete or near complete 
absence of Porphyromonas gingivalis at almost all the sites at 21st day in test group (at 
baseline about 66.7% (++) of P.gingivalis were present which was completely absent 
at 21st day and 13.3% of (+++) P.gingivalis were present at baseline and completely 
absent at 21st day as shown in table – 8 &graph - 6).   
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   But in control sites Porphyromonas gingivalis was present in some sites post 
operatively at 21st day (at baseline about 60% of (++) P.gingivalis were present which 
was reduced to 3.3% at 21st day and 6.7 % of (+++) P.gingivalis were present at 
baseline and completely absent at 21st day as shown in table – 8 &graph - 6). The 
reason for reduced P.gingivalis level after the placement of tulsi gel is probably due to 
the antibacterial activity elicited by one of the important component eugenol. This is 
in accordance with the study done by Singh S et al (2005)46Hence the efficacy of 
10% tulsi gel in reducing the Porphyromonas gingivalis is significant when compared 
to SRP alone. 
In the present study, both the clinical and microbiological parameters changes 
from baseline to 21st day of periodontal intervention shows the effectiveness of  tulsi 
when used as an adjunct therapy to conventional periodontal treatment. 
Correlating the above findings the study infers that “Tulsi as a potential herb”, 
in any form can be used to treat gingival and periodontal disease with the advantages 
of being easily available, less toxic, and less expensive when compared to the 
chemical agents. 
 
 
 
 
SUMMARY &  CONCLUSION
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The present study is one of its kind, because the human studies related to the 
use of tulsi gel in the treatment of periodontitis were not reported in the past. Hence 
this study involved a comparative clinical evaluation of 10% tulsi gel and SRP alone 
in the treatment of chronic periodontitis. The study population comprised of 30 
healthy subjects and 60 sites each with 5mm to 6mm bilateral probing pocket depth 
were randomly divided into test and control groups. Tulsi gel were prepared at various 
concentrations like (2 %, 4%, 10% and 15%) then invitro antimicrobial efficacy were 
evaluated among the concentrations to know the exact concentration at which 
maximum antimicrobial action is achieved among the concentrations 10% had 
maximum MIC . 
10% tulsi gel was inserted in the test site, while SRP alone in control site. 
Subgingival plaque samples were collected at baseline and 21st day to evaluate 
P.gingivalis levels. Clinical parameters like Plaque index (PI), Gingival index (GI), 
Sulcus bleeding index (SBI), Probing pocket depth (PPD), Relative attachment level 
were assessed at baseline and 21st day. The microbiological assessment were done by 
qualitatively assessment of P.gingivalis from the samples obtained at baseline and 21st 
day of both control and test groups. The obtained results infer that test group showed 
better clinical and microbiological improvements with the efficacy 10% tulsi gel as an 
adjunct to SRP compared to the control group with SRP alone. 
Thus we conclude that the local drug delivery in gel from can be used as an 
adjunct to SRP and tulsi with its high medicinal value, easy availability, less toxic and 
less expensive can be used as an adjunct in to treat gingival and periodontal disease. 
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